Phi Optics
Phi Optics provides Quantitative Phase Imaging (QPI) technology that enhances existing optical microscopes to offer 4D, label-free, quantitative imaging of live cells, tissues, and organoids. Their solutions, including CellVista SLIM™, CellVista GLIM™, and CellVista AI, enable non-invasive, real-time imaging with superior contrast and resolution compared to traditional microscopy. This technology quantifies intrinsic properties like dry mass and refractive index, facilitating detailed analysis of cell dynamics, particle analysis, neuroscience research, and 3D cell tomography without harming specimens. Phi Optics aims to advance biological sciences and drug discovery by offering label-free, high-throughput imaging solutions that are compatible with standard microscopy platforms and generate data suitable for machine learning.
Phi Optics
Phi Optics provides Quantitative Phase Imaging (QPI) technology that enhances existing optical microscopes to offer 4D, label-free, quantitative imaging of live cells, tissues, and organoids. Their solutions, including CellVista SLIM™, CellVista GLIM™, and CellVista AI, enable non-invasive, real-time imaging with superior contrast and resolution compared to traditional microscopy. This technology quantifies intrinsic properties like dry mass and refractive index, facilitating detailed analysis of cell dynamics, particle analysis, neuroscience research, and 3D cell tomography without harming specimens. Phi Optics aims to advance biological sciences and drug discovery by offering label-free, high-throughput imaging solutions that are compatible with standard microscopy platforms and generate data suitable for machine learning.